D-0251-2021 Class III Terminated
FDA drug recall D-0251-2021 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Feb 5, 2021 and is designated Class III. Reason for recall: Failed Impurity/Degradation Specifications The recall status is terminated (terminated Nov 3, 2021). Affected quantity: 20,475 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 17, 2021
- Initiation Date
- Feb 5, 2021
- Termination Date
- Nov 3, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 20,475 vials
Product description
Pantoprazole Sodium for Injection 40mg/vial For I.V. infusion only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 62756-129-40
Reason for recall
Failed Impurity/Degradation Specifications
Distribution pattern
Nationwide
Code information
JKU3595A, JKU3596A, JKU3597A, and JKU3629A; Exp 02/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0251-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026